Pyrotinib Combined With Capecitabine As First-Line Therapy For Her2-Positive Metastatic Breast Cancer: A Pooled Analysis Of Three Randomized Controlled Trials.

Zefei Jiang,Binghe Xu,Min Yan,Quchang Ouyang,Xi-Chun Hu, Wei Li,Ji Feng Feng,Qingyuan Zhang,Zhongsheng Tong,Ping Yan,Xiaoyu Zhu,Shangyi Rong,Jianjun Zou

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 1|浏览54

暂无评分

摘要

e13022Background: Anti-HER2 agents combined with chemotherapy is the treatment strategy for treatment-naive HER2-positive relapsed or metastatic breast cancer. This pooled study was conducted to in...

查看译文

关键词

Metastatic Breast Cancer,Breast Cancer,HER2

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要